| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $8,987,015 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI162989 | Targeted Pan-Antifungal Liposomes | 000 | 5 | NIH | 1/20/2026 | $532,736 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 001 | 1 | NIH | 1/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 000 | 1 | NIH | 1/16/2026 | $43,700 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31DK141239 | A process evaluation of a pragmatic randomized controlled trial to promote mental health among adults with Type 1 diabetes | 000 | 2 | NIH | 12/19/2025 | $43,828 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 4 | NIH | 2/11/2026 | $73,682 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 4 | NIH | 2/5/2026 | $111,577 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM128620 | Biosensor-driven Platforms for Biosynthesis of Natural Products in Bacteria | 000 | 8 | NIH | 12/22/2025 | $353,810 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 000 | 4 | NIH | 12/15/2025 | $394,110 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM157138 | Characterizing the regulation of cell envelope biosynthesis in Pseudomonas aeruginosa | 000 | 2 | NIH | 12/12/2025 | $325,168 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153272 | Indole Alkaloids and Halogenated Phenazines: Platforms for Discovery | 000 | 4 | NIH | 1/19/2026 | $331,600 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 000 | 3 | NIH | 1/13/2026 | $490,327 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM149230 | Mechanism and Inhibition of Histone Modifications | 000 | 4 | NIH | 1/19/2026 | $335,675 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS135412 | Characterizing and treating peripheral nervous system dysfunction in Sanfilippo Syndrome | 000 | 2 | NIH | 2/5/2026 | $188,750 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182884 | Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussis | 000 | 2 | NIH | 12/4/2025 | $181,080 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119517 | Novel Modulators of TGFß1 signaling in regulation of remyelination by neural stem cells | 000 | 5 | NIH | 12/5/2025 | $335,675 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 3 | NIH | 2/13/2026 | $455,140 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD110099 | The Role of the O-GlcNAc Modification in X-linked Intellectual Disability | 000 | 4 | NIH | 1/28/2026 | $333,642 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 12 | NIH | 1/21/2026 | $339,923 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES036241 | Novel Epitranscriptomic Mechanisms in Metal Neurotoxicity | 000 | 2 | NIH | 12/17/2025 | $448,960 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 000 | 5 | NIH | 2/6/2026 | $600,217 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES034196 | Role of Prokineticin 2 in Metal Neurotoxicity | 000 | 4 | NIH | 12/22/2025 | $349,842 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 4 | NIH | 2/11/2026 | $54,644 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 4 | NIH | 2/5/2026 | $624,074 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 4 | NIH | 12/10/2025 | $331,600 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 000 | 4 | NIH | 2/12/2026 | $405,192 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI150098 | The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii | 000 | 7 | NIH | 1/9/2026 | $579,302 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01DA059329 | Trauma-informed, resilience-based telehealth intervention for improving HIV prevention and HCV care for persons who inject drugs in the Deep South | 000 | 3 | NIH | 1/29/2026 | $187,709 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 4 | NIH | 12/8/2025 | $477,462 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SM084376 | Connecting Extension with Communities to Reduce Mental Health Stigma | 000 | 3 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SM084376 | Connecting Extension with Communities to Reduce Mental Health Stigma | 001 | 3 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | NU58DP007332 | Healthier Together: High Obesity Program in Georgia | 01 | 3 | CDC | 12/15/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | NU58DP007332 | Healthier Together: High Obesity Program in Georgia | 01 | 3 | CDC | 12/15/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 000 | 4 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM118160 | CRISPR Capture, Destroy, and Counter-Attack Mechanisms | 000 | 10 | NIH | 2/3/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HL168507 | A deep learning-enhanced multiphysics and multiscale framework for predictive modeling of inflammation-induced thrombosis | 000 | 2 | NIH | 11/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI175925 | Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome | 000 | 2 | NIH | 11/13/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 000 | 8 | NIH | 10/8/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK133325 | Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease | 000 | 4 | NIH | 2/11/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK138306 | Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids | 000 | 1 | NIH | 12/12/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA252713 | Canine MHC-I genotyping and tumor specific neoantigen determination | 000 | 5 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG093018 | Navigating the Transition to Middle Age in the Strong African American Healthy Adults Project (SHAPE) | 000 | 1 | NIH | 1/30/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP5OD029792 | The Molecular Basis of Caste Development and Evolution in Ants | 001 | 6 | NIH | 1/21/2026 | $1 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP5OD029792 | The Molecular Basis of Caste Development and Evolution in Ants | 001 | 6 | NIH | 1/21/2026 | $165,751 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90DDUC0127 | IHDD-UCEDD FY2023-2027 | 02 | 4 | ACL | 1/22/2026 | $226,761 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90DDUC0127 | IHDD-UCEDD FY2023-2027 | 02 | 4 | ACL | 1/22/2026 | -$226,761 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32AI060546 | Training in Tropical and Emerging Global Diseases | 000 | 20 | NIH | 11/19/2025 | -$96,195 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T03OH012806 | Translating the Fisherman First Aid and Safety Training (FFAST) for Commercial Fishermen in the Southeastern United States | 02 | 1 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 000 | 2 | NIH | 12/1/2025 | $0 |
|
